药物对比
Erenumab vs Galcanezumab
比较Erenumab(Aimovig)与Galcanezumab(Emgality)用于偏头痛预防。Erenumab靶向CGRP受体,而Galcanezumab结合配体。两种单克隆抗体显示出相似的疗效和给药方案,但副作用和患者反应有所不同。了解关键差异以选择最佳方案。
此页面暂无可用的对比维度。
临床背景
Patients with episodic or chronic migraine seeking CGRP monoclonal antibody prevention often compare Erenumab and Galcanezumab.
结论
Both Erenumab and Galcanezumab are effective CGRP inhibitors for migraine prevention, with the better option depending on individual patient factors.
全部药物对比